Blog & News

More blog posts

The New ICH E6 (R3) Guidelines: Impact on Clinical Trials

The New ICH E6 (R3) Guidelines: Impact on Clinical Trials

In anticipation of the new ICH GCP E6(R3) guidelines, which are due to be implemented in August / September 2024, as Arithmos we would like to discuss the evolution of clinical trial designs and proportional risks.

A Letter from our CEO

A Letter from our CEO

Paolo Morelli, Founder and CEO of Arithmos, would like to thank our customers, partners, and employees for working together in 2023 towards creating better lives for patients around the world.
Read some thoughts on the Arithmos year.

Get an assessment

Contact us now for receiving further information and an assessment from our experts.
We will evaluate with you the best approach for your business processes.

Get an assessment

Contact us now for receiving further information and an assessment from our experts.
We will evaluate with you the best approach for your business processes.